Executive Summary
This stream covers 23 Officer Change and Director Change 8-Ks dated October 20, 2026, and the dominant theme is leadership renewal rather than distress: most filings are board additions or orderly succession (retirements, planned transitions, new CFOs or COOs) with no quantified financial results.
The clearest quantitative signal comes from Neptune Insurance Holdings, which reported record Q3 2026 results (revenue +34.3% YoY to $59.6M, net income +49.9%, written premium +31% to $132.7M) but where twelve-month net income was flat and net income margin fell 7.6pp to 22.7%, with share-based compensation jumping from $0.1M to $7.0M. Clearfield's CEO retirement carries the most near-term event risk, with its fiscal Q4 and full-year results (in line with guidance) due November 10, 2026 and a CEO search launching now. Several governance-driven situations stand out: Laser Photonics' CFO appointment is paired with outside securities and reporting counsel, signaling remediation of financial accountability, while PDS Biotechnology replaced four directors and Silvia (formerly ProCap) announced a >$10M cost-cutting program alongside executive additions. Board refreshes across pharma and biotech (Vertex, Insmed, Inhibikase, PDS) and financial services (Northern Trust, Whirlpool, Apollo) point to a sector pattern of adding commercial, regulatory, and capital-markets expertise ahead of late-stage development or growth initiatives. Overall the stream is largely neutral-to-positive, with the notable exceptions being the governance and cost-reset situations at Laser Photonics, PDS, and Silvia.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from October 19, 2026.
Investment Signals (12)
- Neptune Insurance Holdings ↓ (BULLISH)▲
Record Q3 2026 revenue $59.6M (+34.3% YoY), net income +49.9% to $17.3M, Adjusted EBITDA +37.5%, written premium +31% to record $132.7M; quality of growth tempered by flat twelve-month net income
-
Option repricing to $12.26 approved by 441.1M votes for vs 232.5M against, restoring retention value without added overhang; CEO Jeff Green's performance options excluded [MIXED/BULLISH]
- Newell Brands ↓ (BULLISH)▲
Guillermo Beade (ex-President of SC Johnson North America) named COO effective Oct 26, 2026 with enterprise accountability for global sales, marketing and supply chain, following prior portfolio simplification
- Vertex Pharmaceuticals ↓ (BULLISH)▲
Former Boston Scientific CFO Daniel Brennan joins the board and the Audit and Finance Committee with a $400K RSU award, adding seasoned audit-level financial oversight
- Insmed ↓ (BULLISH)▲
Board adds Paul Hudson (ex-CEO of Sanofi and Novartis Pharmaceuticals) and Utpal Koppikar (CFO of Verily), bolstering commercial and capital-markets depth ahead of respiratory and immunology programs
- Northern Trust ↓ (BULLISH)▲
Rima Qureshi (ex-Verizon chief strategy officer, 15 years on Mastercard board) added to board effective immediately, adding transformation and digital-strategy expertise
- Entravision Communications ↓ (BULLISH)▲
Two independent directors (Ferrera to Audit Committee, Krzanich) lift board from seven to nine members, with no related-party interests disclosed
- Laser Photonics ↓ (MIXED)▲
New CFO Tim Peterson-level appointment (Tim Peterman, ex-iMedia Brands CEO/CFO) paired with Sheppard Mullin and CBIZ engagements signals remediation of financial reporting controls; positive if reporting quality improves
-
CEO Cheri Beranek retiring March 31, 2027 (co-founder since 2008), with fiscal 2026 Q4/full-year results tracking prior guidance per preliminary data [NEUTRAL/CAUTION]
- Silvia (formerly ProCap Financial)▲
Company-wide cost cuts targeting >$10M annualized savings via compensation, compute and vendor renegotiations; impact not yet quantified in detail [MIXED/BULLISH]
- Apollo Global Management ↓ (BULLISH)▲
Meyer Malka (Ribbit Capital founder, Robinhood director) joins board Jan 1, 2027, expanding to 14 directors with two-thirds independence maintained
- Huntington Ingalls ↓ (BULLISH)▲
Former CEO Mike Petters returns to board, a shipbuilding-expertise addition as HII ramps capacity for U.S. Navy programs
Risk Flags (9)
- Neptune Insurance Holdings/Margin Quality↓ [MEDIUM-HIGH RISK]▼
Twelve-month net income margin fell 7.6pp to 22.7% with net income flat (+0.1%), and nine-month net income margin contracted 2.2pp; share-based compensation rose from $0.1M to $7.0M, driving a wide gap between Adjusted and GAAP earnings
- Laser Photonics/Financial Accountability↓ [HIGH RISK]▼
CFO appointment and outside securities/accounting consultants engaged to 'establish financial accountability' implies prior reporting or control weaknesses; no quantitative results disclosed to confirm remediation
- PDS Biotechnology/Board Turnover↓ [HIGH RISK]▼
Four directors (Glover, Ali-Jackson, Freitag, Brawley) resigned and three replaced effective Oct 18, 2026, including reconstituted Audit and Compensation committees ahead of a Phase 3 PDS0301 trial; the scale of turnover warrants scrutiny of execution continuity
- Silvia (formerly ProCap)/Cost Reset [MEDIUM-HIGH RISK]▼
A >$10M cost-cutting program alongside 'new executive team members' and a name change with ticker change to SVIA suggests a restructuring; management has not quantified the impact
- Clearfield/CEO Succession↓ [MEDIUM RISK]▼
Founder-CEO Cheri Beranek departs March 31, 2027 with no successor named and a search just launching; key-person and execution risk in product and market expansion
- Trade Desk/Option Repricing and Governance↓ [MEDIUM RISK]▼
Repricing approved with 232.5M votes against and Class B shares carrying 10 votes each concentrate influence; repriced options revert if employees leave before April 19, 2027, and reflects weak retention value in the existing equity grants
- Ribbit/Apollo Interlock [LOW-MEDIUM RISK]▼
Malka's board seat at Apollo overlaps with Robinhood board service, and Koppikar's C4 Therapeutics seat alongside Insmed is a potential interlocking-directorship consideration
- Southwest Gas/Key Executive Exit↓ [LOW-MEDIUM RISK]▼
Chief Administrative Officer Randall Gabe retiring by June 1, 2027 while shifting to business development for the 2028 Great Basin Expansion; continuity risk for administration and emerging-technology initiatives
- Live Oak Bancshares/Technology Leadership Vacancy↓ [MEDIUM RISK]▼
Chief Information & Digital Officer Renato Derraik departs November 6, 2026 with no successor named, a gap in digital strategy at a bank with an active technology agenda
Opportunities (8)
- Neptune Insurance Holdings/Growth Catalyst↓ (OPPORTUNITY)◆
Written premium +31% to a record $132.7M and revenue +34.3% suggests sustained top-line momentum; monitor whether Adjusted EBITDA margin expansion (+1.5pp YoY) converts to GAAP margin recovery
- Newell Brands/Operational Turnaround↓ (OPPORTUNITY)◆
COO appointment (Beade, effective Oct 26, 2026) consolidating global sales, marketing and supply chain under one executive following portfolio simplification; supports a margin recovery thesis if execution follows
- Vertex Pharmaceuticals/Governance Strength↓ (OPPORTUNITY)◆
Board expands to eleven with a seasoned CFO on the Audit and Finance Committee, a positive for capital allocation discipline with no related-party issues disclosed
- Insmed/Commercial Scale-Up↓ (OPPORTUNITY)◆
Hudson's Sanofi and Novartis commercial background plus Koppikar's CFO experience signal preparation for commercial launches and capital markets activity across Respiratory, I&I and rare neuro
- Silvia (formerly ProCap)/Cost Efficiency Reset (OPPORTUNITY)◆
>$10M annualized savings target with full run-rate benefit after the current fiscal year; a cost-base reset could lift margins if the savings are realized and disclosed at the next financial update
- Huntington Ingalls/Shipbuilding Capacity Push↓ (OPPORTUNITY)◆
Mike Petters' return to the board with a 1987-to-2022 industry tenure, as HII ramps capacity for U.S. Navy demand; governance support for shipbuilding throughput
- Apollo Global Management/Private Markets Expertise↓ (OPPORTUNITY)◆
Malka's venture and fintech background joins as Apollo's board expands to 14, suggesting a tilt toward technology-enabled alternative asset investing
- Clearfield/Founder Continuity↓ (OPPORTUNITY)◆
Beranek remains as CEO Emeritus post-succession, and fiscal Q4 results tracking guidance (reported Nov 10, 2026) provide a near-term data point to de-risk the transition
Sector Themes (6)
- Board Refreshes Add Pharma and Biotech Commercial Expertise◆
Vertex (Brennan), Insmed (Hudson, Koppikar), Inhibikase (Wasserman), PDS (Dawson, Ramsdell, Wendel) all add directors with Phase 3, commercial or CFO backgrounds; 5 of 23 filings are biotech/pharma board changes, pointing to late-stage pipeline preparation [IMPLICATION: expect more pharma board reconstitutions ahead of Phase 3 readouts]
- Financial Services Governance and Strategy Upgrades◆
Northern Trust (Qureshi), Whirlpool (Risi, with Vanguard and SEI experience), Apollo (Malka), StubHub (Raab), FHLB Des Moines (Manning as CBO) emphasize asset management, strategy and wealth expertise [IMPLICATION: boards are prioritizing asset-management and digital distribution knowledge]
- Orderly CEO and Executive Succession Among Founders and Long-Tenure Leaders◆
Clearfield (Beranek, co-founder), Southwest Gas (Gabe, 30 years), TJX (Canestrari), Live Oak (Derraik), Fox (Ciongoli) show planned transitions with extended advisory or emeritus roles [IMPLICATION: succession planning is dominant, lowering abrupt-departure risk across the stream]
- Finance and Reporting Leadership Reinforcement◆
Laser Photonics (CFO plus outside counsel and CBIZ), Vertex (ex-CFO to Audit Committee), Entravision (Audit Committee addition), AST SpaceMobile (combined CFO/CLO employment agreement) reflect heightened audit and securities-counsel focus [IMPLICATION: watch small-cap issuers for reporting remediation]
- Cost Discipline and Compensation Realignment◆
Silvia's >$10M savings, Trade Desk's option repricing to $12.26, Neptune's share-based comp rising to $7.0M from $0.1M, AST's severance and RSU terms show compensation design being revisited in both directions [IMPLICATION: equity compensation is a key variable in reported earnings quality]
- Interlocking Directorships and Board Network Overlap◆
Malka (Robinhood and Apollo), Koppikar (C4 Therapeutics and Insmed), Engel (Allient, Alaska Power & Telephone, Heartland), Wendel (ImmunityBio), Qureshi (BT Group, Loblaw, Swift) show dense cross-board networks [IMPLICATION: review independence and interlock disclosures in proxy statements]
Watch List (8)
-
Results due November 10, 2026, to be in line with prior guidance; CEO search launched with March 31, 2027 retirement date
-
Repriced options revert to original exercise prices if employees depart or exercise before April 19, 2027; watch for retention outcomes and any Class B voting developments
- Silvia (formerly ProCap)/Savings Disclosure👁
Management to provide cost-savings detail at the next regularly scheduled financial update; watch for quantification of the >$10M target and executive roster changes
-
New CFO Tim Peterman's first filings and any restatement or control disclosures under Sheppard Mullin and CBIZ engagements
-
Reconstituted board and new Audit and Compensation committees ahead of the PDS0301 Phase 3 trial in metastatic colorectal cancer and PDS0101 partnership efforts
-
Reported Q3 2026 net income margin trajectory and whether share-based comp ($7.0M) continues to widen the GAAP vs Adjusted EBITDA gap; officer change under Item 5.02 to be reviewed
-
Beade takes the COO role Oct 26, 2026, with a mandate to link sales, marketing and supply chain; watch for organizational announcements and margin commentary
-
Brennan's first Audit and Finance Committee cycle and any commentary on capital allocation after the board expansion to eleven
Filing Analyses
(23)
20-10-2026
Vertex Pharmaceuticals appointed Daniel Brennan, former EVP and Chief Financial Officer of Boston Scientific (retired June 2025), as a new independent board member on October 20, 2026, expanding the Board from ten to eleven members. Mr. Brennan also joined the Audit and Finance Committee and received a $400,000 restricted stock unit award vesting in October 2027. The filing discloses no related-party transactions or undisclosed arrangements tied to the appointment.
- · Mr. Brennan was appointed to the Audit and Finance Committee at the time of joining the Board
- · Prior roles: EVP and CFO of Boston Scientific (Jan 2014 to Jun 2025); SVP and Corporate Controller (2010 to 2013); various finance roles (1996 to 2009)
- · Current outside board seats: Waters Corporation (since Nov 2022) and Madrigal Pharmaceuticals (since Aug 2025); former director of Nuance Corporation until its acquisition by Microsoft in March 2022
- · Education: B.S. in Finance and Investments and M.B.A. from Babson College; certified public accountant
- · Non-employee director compensation policy is detailed in Exhibit 10.45 to the FY2025 Form 10-K
- · No Item 404(a) related-person transactions and no arrangement or understanding with other persons regarding the appointment
20-10-2026
Fox Corporation announced that Adam Ciongoli, Chief Legal and Policy Officer, will not renew his contract and will step down effective December 1, 2026, transitioning to a special advisor role through June 2028. Nicholas Trutanich, currently Executive Vice President and Principal Deputy General Counsel, will become General Counsel effective the same date, reporting to Executive Chair and CEO Lachlan Murdoch. The change is a leadership succession within the legal function rather than a financial or operational event, with no financial metrics disclosed.
- · Kristopher Jones, EVP and Head of Government Relations, will report directly to John Nallen, President and COO, effective December 1, 2026
- · Trutanich previously served as U.S. Attorney for the District of Nevada (2019 to 2021) and joined Fox in 2021 as Chief Ethics & Compliance Officer
- · Ciongoli's advisory role runs through June 2028, providing continuity of institutional knowledge
20-10-2026
Insmed Incorporated (Nasdaq: INSM) appointed two new independent directors to its Board effective October 20, 2026: Paul Hudson, former CEO of Sanofi S.A. (September 2019 through February 2026) and former CEO of Novartis Pharmaceuticals, and Utpal Koppikar, CFO of Verily Health Inc. since April 2023 and former EVP and CFO of Atara Biotherapeutics. The filing is a board appointment announcement with no financial results, deal terms, or quantitative performance data disclosed.
- · Koppikar currently serves on the Board of Directors of C4 Therapeutics, Inc. (Nasdaq: CCCC), a potential interlocking-directorship consideration
- · Insmed's therapeutic focus areas are Respiratory, Immunology & Inflammation, and Neuro & Other Rare
- · Insmed's research engine spans gene therapy, AI-driven protein engineering, RNA end-joining, and synthetic rescue
20-10-2026
Laser Photonics Corp (NASDAQ: LASE) announced the appointment of Tim Peterman as Chief Financial Officer on October 20, 2026. The appointment, alongside the engagement of Sheppard, Mullin, Richter & Hampton LLP as outside securities counsel and CBIZ, Inc. for external financial reporting consulting, is framed by management as part of efforts to establish financial accountability, strengthen reporting processes and build governance. Mr. Peterman previously served as CEO of iMedia Brands (May 2019 to August 2023) and as its CFO (March 2015 to April 2018).
- · Mr. Peterman holds a Bachelor of Science in accounting from the University of Kentucky and is a CPA with an inactive license
- · Mr. Peterman began his career at KPMG in Chicago in 1989
- · Sheppard will advise on securities law, SEC reporting obligations, corporate governance and capital markets matters
- · CBIZ will help adopt best practices in external financial reporting and strengthen internal financial reporting controls and documentation
20-10-2026
TJX Companies disclosed on October 15, 2026 that Senior Executive Vice President and Group President Kenneth Canestrari will step down as an executive officer effective January 31, 2027, while remaining employed until his scheduled retirement on April 30, 2027. The letter agreement extends his employment agreement to April 30, 2027, and removes him from the Management Incentive Plan, LRPIP (for performance periods beginning fiscal 2028 or later) and new SIP equity grants. The change is an orderly, pre-planned transition, with continuing non-compete and confidentiality obligations.
- · Canestrari's employment agreement, dated February 2, 2018 and last amended February 2, 2024, is extended to April 30, 2027
- · He ceases to be an executive officer effective January 31, 2027, but remains a Senior Executive Vice President until April 30, 2027
- · He will receive special service recognition benefits on existing LRPIP and SIP awards after retirement, subject to plan terms
20-10-2026
Clearfield, Inc. (NASDAQ: CLFD) announced that CEO and co-founder Cheri Beranek will retire as President and Chief Executive Officer effective March 31, 2027, and will remain at the company as President and CEO Emeritus in a non-director role after her successor is appointed. The Board, chaired by Catherine T. Kelly, will launch a search with a nationally recognized firm considering internal and external candidates. The company also expects fiscal 2026 fourth-quarter and full-year results to be in line with prior guidance, based on preliminary unaudited information, with results to be reported November 10, 2026.
- · Beranek co-founded Clearfield in 2008 and is credited as key architect of product and market expansion
- · Beranek remains in her role until the earlier of successor appointment or March 31, 2027
- · Fiscal 2026 Q3 earnings call was held August 5, 2026, the reference point for Q4/full-year guidance
- · Clearfield deploys more than a million fiber ports each year
20-10-2026
The Federal Home Loan Bank of Des Moines announced that Brett Manning has been appointed chief business officer, effective October 16, 2026, succeeding Wil W. Osborn, who became president and chief executive officer on October 1, 2026. Manning, who has been with the Bank since 1998 and most recently served as director of Member Strategies & Solutions, brings nearly 30 years of experience to the role. The filing reports a leadership transition only and contains no quantitative financial results.
- · Manning joined the Bank in Seattle in 1998 and has held several business development and front-line risk management roles.
- · Osborn previously served as chief business officer before becoming president and CEO on October 1, 2026.
- · Manning holds a bachelor's degree in finance (minor in economics) from Western Washington University and is a Chartered Financial Analyst charterholder.
20-10-2026
Whirlpool Corp. appointed Karin Risi to its board of directors effective immediately (announced October 19, 2026), with a seat on the Finance and Human Resources committees. Risi is a former Vanguard managing director and chief strategy and product officer with 28 years at Vanguard and more than 30 years of asset and wealth management experience. The filing is a board appointment rather than an executive departure, and it contains no financial results or guidance.
- · Risi holds a bachelor's degree in finance and an MBA from Villanova University
- · Risi currently serves as an independent director of SEI Investments Company and HarbourVest Partners
- · Risi previously led the build and launch of Vanguard's Personal Advisor wealth management business
- · Whirlpool describes itself as the only major U.S.-based manufacturer of kitchen and laundry appliances
20-10-2026
Northern Trust (NTRS) announced the appointment of Rima Qureshi, former executive vice president and chief strategy officer of Verizon Communications, to its board of directors, effective immediately. Qureshi brings nearly four decades of strategy and transformation experience, including 23 years at Ericsson and more than 15 years on public company boards, including 15 years on the Mastercard board. The filing contains no financial results, so no period-over-period performance metrics are reported.
- · Qureshi currently serves on the boards of BT Group plc, Loblaw Companies Limited and Swift
- · Qureshi previously served as chief executive officer of Ericsson North America
- · Qureshi joined Verizon in 2017
20-10-2026
Neptune Insurance Holdings (NYSE: NP) reported record third quarter 2026 results, with revenue up 34.3% YoY to $59.6M, net income up 49.9% to $17.3M (29.0% margin), and Adjusted EBITDA up 37.5% to $36.8M (61.7% margin). Written premium grew 31% to a record $132.7M. However, Adjusted EBITDA margin (61.7%) is only modestly higher than the prior year (+1.5pp), nine-month net income margin contracted 2.2pp YoY, and twelve-month net income was essentially flat (+0.1%) as net income margin fell 7.6pp to 22.7%. Share-based compensation rose sharply to $7.0M from $0.1M, a major driver of the gap between Adjusted and GAAP earnings. The filing also references an officer change under Item 5.02.
- · Nine-month revenue rose 32.3% to $153.2M; nine-month net income grew 22.2% to $40.4M, but net income margin fell 2.2pp to 26.4%
- · Twelve-month net income margin fell 7.6pp to 22.7% while twelve-month net income was flat at $44.7M
- · Q3 interest expense (net of interest income) fell 37.9% to $3.3M, supporting earnings
- · Q3 income tax expense rose 88.7% to $7.5M, a meaningful drag on net income growth
- · Share-based compensation rose to $7.0M in Q3 from $0.1M, widening the gap between GAAP and adjusted earnings
- · Item 5.02 (officer change) is disclosed in this 8-K but its details are not included in the provided exhibit text
20-10-2026
Randall P. Gabe, Senior Vice President and Chief Administrative Officer of Southwest Gas Corporation, notified the company on October 20, 2026 of his intention to retire on or before June 1, 2027, after 30 years of service. Until then he will serve as Senior Vice President/Business Development, supporting the 2028 Great Basin Expansion project and overseeing the Emerging Technology and Innovation team. The filing states the retirement was not the result of any disagreement with the company or Southwest Gas Holdings on operations, policies, or practices.
- · Retirement is effective on or before June 1, 2027
- · Gabe's new role is Senior Vice President/Business Development, with responsibility for the Emerging Technology and Innovation team through the effective date
- · The filing explicitly states no disagreement with the company on operations, policies, or practices
20-10-2026
AST SpaceMobile entered into a new three-year executive employment agreement with Andrew M. Johnson, its EVP, CFO and Chief Legal Officer, effective October 14, 2026, superseding his prior agreement. The agreement sets a base salary of not less than $250,000, bonus eligibility, RSU eligibility under the 2024 Incentive Award Plan, and severance of 12 months' base salary plus up to 12 months of COBRA subsidy and accelerated vesting on termination without Cause, for Good Reason, or on non-renewal.
- · Johnson's agreement carries a non-compete and confidentiality/invention assignment covenants under a previously executed agreement, with severance conditioned on a release of claims and continued compliance
- · Johnson holds the combined CFO and Chief Legal Officer roles, and is also an Eligible Employee under the change-of-control severance policy
- · Filing was signed October 20, 2026, six days after the October 14, 2026 effective date of the agreement
20-10-2026
Apollo Global Management announced that Meyer "Micky" Malka, founder and managing partner of Ribbit Capital, will join its Board of Directors effective January 1, 2027, expanding the board to 14 directors while maintaining a two-thirds independent composition. The appointment is a board addition rather than an executive change, and the release is a routine governance announcement with no reported financial results or performance metrics.
- · Malka currently serves on the board of Robinhood Markets, Inc.
- · Malka co-founded Heptagon Group, Banco Lemon, and Bling Nation/Lemon Inc.; Patagon.com was acquired by Banco Santander in 2000 and Banco Lemon by Banco do Brasil in 2009
- · Malka holds an economics degree from the Universidad Católica Andrés Bello in Caracas, Venezuela
- · Gary Cohn, as Lead Independent Director, praised Malka's entrepreneurial track record and global perspective
20-10-2026
Inhibikase Therapeutics (Nasdaq: IKT) appointed Scott M. Wasserman, MD, to its Board of Directors effective October 19, 2026, while Dennis Berman resigned from the Board concurrently. Dr. Wasserman is currently Chief Medical Officer of Kailera Therapeutics and brings more than two decades of cardiology and clinical development experience, including senior roles at Amgen in the development of Repatha, Evenity, and Aimovig. The announcement is a board governance change with no disclosed financial figures.
- · Board appointment effective October 19, 2026, one day before the October 20, 2026 announcement
- · Dennis Berman's resignation from the Board was announced concurrently with the appointment
- · Dr. Wasserman previously served as Venture Partner at Frazier Life Sciences and as CEO and co-founder of Latigo Biotherapeutics
- · Filing references Items 5.02, 7.01 and 9.01, with the press release furnished as Exhibit 99.1
20-10-2026
Silvia, Inc. (formerly ProCap Financial, Inc.; Nasdaq: SVIA) announced an aggressive company-wide cost-cutting initiative expected to generate more than $10 million in annualized savings, achieved through reductions in compensation and operating expenses, lower compute and personnel costs, and renegotiated vendor contracts. The release also cites the addition of new executive team members at a more efficient cost structure, and Anthony Pompliano is identified as Chairman and CEO. The filing does not provide the specific officer change details that would normally accompany Items 5.02 disclosures, and the savings are expected to begin in the current fiscal year with full run-rate benefit thereafter.
- · Company was formerly ProCap Financial, Inc. and changed its name to Silvia, Inc. with a new Nasdaq ticker SVIA
- · Savings attributed to reduced compute and personnel expenses, renegotiated key vendor contracts, and addition of executives at a more efficient cost structure
- · Management has not quantified the impact in detail and will provide additional details at the next regularly scheduled financial update
- · Filing references Item 5.02 (officer departure/election) but the exhibit contains no departure or appointment particulars
- · Company describes itself as the first publicly traded agentic finance firm and references a website transition in forward-looking statements
20-10-2026
Entravision Communications Corporation (NYSE: EVC) appointed Gary Ferrera and Brian Krzanich as independent directors on October 14, 2026, expanding the Board from seven to nine members. Mr. Ferrera joins the Audit Committee; both receive standard non-employee director compensation, including a prorated initial RSU grant. The filing discloses no material financial results, and no departures are reported.
- · Gary Ferrera was appointed to the Audit Committee
- · Both directors were determined to be independent under NYSE listing standards and Exchange Act rules
- · Neither director has a material interest in any related-party transaction under Item 404(a) of Regulation S-K
- · Directors serve until the 2027 annual meeting of stockholders
- · Ferrera previously served as CFO at MoneyGram, Driven Brands, and Skillsoft; Krzanich was formerly CEO of CDK Global and Intel
- · Compensation references the Non-Employee Director Compensation Policy disclosed in Exhibit 10.14 to a Form 10-Q filed August 4, 2023
20-10-2026
HII announced that former CEO and President Mike Petters has been elected to the company's board of directors, returning to a board role after stepping down as CEO in 2022. CEO Chris Kastner and Chairman Kirkland Donald both praised his shipbuilding expertise as HII ramps up capacity for the U.S. Navy. The filing contains no financial results, so no period-over-period performance comparison applies.
- · Petters stepped down as first CEO and president in 2022 after steering the 2011 spin-off from Northrop Grumman
- · Petters began at Newport News Shipbuilding in 1987 in the Los Angeles-class submarine construction division
- · Petters holds a physics bachelor's degree from the U.S. Naval Academy (1982) and an MBA from the College of William and Mary
- · Petters previously served as chairman of the Virginia Business Council and the Aerospace Industries Association
20-10-2026
Suja Life, Inc. (NASDAQ: SUJA) announced the appointments of Robert B. Engel and Zahir Ibrahim as independent directors effective October 16, 2026, expanding the Board to nine members, seven of whom are independent. Engel will join the Audit Committee, and the appointments add financial, accounting, and capital markets expertise as the company pursues its growth strategy. The filing contains no financial results, quantitative performance metrics, or negative developments.
- · Engel serves as CEO and Managing Director of BLT Advisory Services, LLC, and is an independent director of Allient, Inc. (Audit Committee) and Chairman of Alaska Power & Telephone
- · Engel previously chaired the Risk Committee at Heartland Financial USA, Inc.
- · Ibrahim was most recently CFO of BARK, Inc. and led KIND through its 2020 sale to Mars
- · Ibrahim was earlier CFO of Annie's, Inc., which was sold to General Mills
- · Suja's brands reach consumers through thousands of retail doors nationally; the company operates a vertically integrated high-pressure processing and cold-pressed facility
20-10-2026
The Trade Desk, Inc. effected an option repricing on October 19, 2026, reducing the exercise price of eligible outstanding stock options under its 2025 Incentive Award Plan to $12.26, the closing price on the Effective Date, after stockholders approved the Repricing at a special meeting that day. Options exceeding that closing price were repriced, while incentive stock options and CEO Jeff Green's market-based performance options were excluded. The repricing is intended to restore incentive and retention value without increasing equity overhang.
- · Repriced options revert to original exercise prices if the service provider terminates (other than termination by the Company without cause) or exercises before April 19, 2027
- · Proposal One received 441,097,211 votes for and 232,477,009 against, with 299,747 abstentions; Proposal Two (adjournment) was not needed
- · Class B shares carry 10 votes each, so Class B holders have outsized influence in stockholder votes
- · CEO Jeff Green's market-based performance options granted in October 2021 and September 2026 were excluded from the repricing
20-10-2026
Newell Brands (NASDAQ: NWL) announced the appointment of Guillermo Beade as Chief Operating Officer, effective October 26, 2026, reporting to CEO Chris Peterson and joining the Executive Committee. The COO role carries enterprise accountability for global sales, central marketing, and supply chain, with a mandate to improve connectivity across these functions and strengthen structure, systems, and talent. The filing discloses no quantitative financial results, guidance, or deal terms.
- · Beade previously served as President of SC Johnson Consumer Brands North America and as CEO of SC Johnson Lifestyle Brands
- · Management cites prior simplification of the portfolio and improvements to supply chain and go-to-market models as the basis for the structural change
- · The filing is an 8-K with Items 5.02 and 9.01, and the press release is furnished as Exhibit 99.1
20-10-2026
StubHub Holdings, Inc. (NYSE: STUB) disclosed that its Board of Directors appointed Andrew Raab, Co-Founder of investment firm FPR Partners, to fill an existing vacancy as a director effective October 16, 2026, with a term expiring at the 2027 annual meeting. Raab is not expected to serve on any Board committee. The filing also discloses a prior consulting agreement (dated March 27, 2026) with Raab for a three-year term, with RSUs granted at an aggregate grant date fair value of $200,000, and a prior $2.0 million Series O preferred stock purchase by Raab in August 2025.
- · Raab's director term expires at the Company's 2027 annual meeting of stockholders
- · Raab previously served as Principal at Hellman and Friedman, Associate at Bain Capital, and Analyst at Donaldson, Lufkin and Jenrette; holds MBA from Stanford GSB and BA from University of Michigan
- · Raab's director compensation follows the non-employee director program disclosed in the FY2025 10-K filed March 5, 2026 and the proxy filed April 30, 2026
- · Company will enter its standard indemnification agreement with Raab
- · Filing discloses a related-party relationship: Raab's prior preferred stock investment and consulting arrangement, which the Company states requires disclosure under Item 404(a) of Regulation S-K
20-10-2026
PDS Biotechnology appointed three new directors (John Dawson CBE, Deborah Ramsdell, and Bruce Wendel), effective October 18, 2026, following the resignations of four existing directors (Stephen Glover, Kamil Ali-Jackson, Gregory Freitag, and Otis Brawley). The board was reconstituted, including new Audit and Compensation committee compositions, to support advancement of PDS0301 toward a Phase 3 trial in metastatic colorectal cancer and partnership efforts for PDS0101. The filing does not disclose financial results, and the governance change is presented as a strategic enhancement rather than a response to a stated performance issue.
- · Board appointments and resignations effective October 18, 2026; announcement dated October 20, 2026
- · Otis Brawley's oncology experience was cited by the CEO as having shaped the clinical development strategy
- · Bruce Wendel currently serves on the board of ImmunityBio; prior board service includes GT BioPharma (Nov 2020 to May 2025) and Verastem (June 2016 to May 2021)
- · Deborah Ramsdell became CEO of Pluvia Biotech in August 2026, a concurrent external leadership role
- · Audit Committee is chaired by James Banaag with John Dawson and Bruce Wendel as members
- · Nominating and Governance Committee includes Dr. Ilian Iliev, who is not a new appointee
Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 23 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Officer Management Changes SEC
October 16, 2026
US Executive Officer Management Changes SEC — October 16, 2026
October 15, 2026
US Executive Officer Management Changes SEC — October 15, 2026
October 14, 2026
US Executive Officer Management Changes SEC — October 14, 2026
October 13, 2026
US Executive Officer Management Changes SEC — October 13, 2026
🇺🇸 More from United States
View all →October 21, 2026
US Pre-Market SEC Filings Roundup — October 21, 2026
US Pre-Market SEC Filings Roundup
October 21, 2026
US Corporate Board Director Changes SEC Filings — October 21, 2026
US Corporate Board Director Changes SEC Filings
October 21, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — October 21, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings
October 21, 2026
US Merger & Acquisition SEC Filings — October 21, 2026
US Merger & Acquisition SEC Filings